At a glance
ClinicalIndex Comparison RecordN/ACompleted· 126 enrolled
Drug / intervention
CONTROL Lens +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Initial Evaluation of Investigational Lenses Manufactured on a New Production Line
In Brief
A clinical study evaluating CONTROL Lens and TEST Lens for Visual Acuity. Completed, enrolled 126 participants across 6 sites.
Detailed Summary
This study is a randomized, 4-visit, subject-masked, 2x3 bilateral crossover, dispensing trial. Each study lens will be worn bilaterally in a daily wear (DW) modality for at least 6 hours per day and 5 days per week for approximately two weeks each. The subject will wear either the Test or Control lens twice and the other study lens once.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVisual Acuity
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartAug 2018
First PostedSep 2018
Primary CompletionOct 2018
TodayJul 2026
First PostedSep 20, 2018
Enrollment StartAug 29, 2018
Primary CompletionOct 31, 2018
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 7.8 years ago
Interventions
CONTROL Lensdevice
Acuvue OASYS
TEST Lensdevice
senofilcon A